Clinical Trial Update: Microvisk Continuous Blood Donation Study [NA]

View source ↗

Summary

Clinical trial update from Microvisk Technologies Ltd indicates a study on pulmonary embolism, deep vein thrombosis, and atrial fibrillation. The trial is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Pulmonary Embolism

Snippet

Sponsor: Microvisk Technologies Ltd | Conditions: Pulmonary Embolism (Diagnosis), Deep Vein Thrombosis | NA | Status: NOT_YET_RECRUITING